C12N 2502/1157
Monocytes, macrophages
C12N2502/1157 (Monocytes, macrophages) appears on 86 US grants and 207 published applications in this corpus.
Search patents in C12N- Granted patents
- 86
- Published applications
- 207
- Assignees
- 140
- Inventors
- 395
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 1 | 1 |
| 2011 | 1 | 2 |
| 2012 | 1 | 2 |
| 2013 | 0 | 6 |
| 2014 | 2 | 3 |
| 2015 | 3 | 2 |
| 2016 | 2 | 7 |
| 2017 | 2 | 10 |
| 2018 | 5 | 13 |
| 2019 | 3 | 17 |
| 2020 | 4 | 14 |
| 2021 | 8 | 27 |
| 2022 | 4 | 22 |
| 2023 | 10 | 17 |
| 2024 | 17 | 23 |
| 2025 | 12 | 22 |
| 2026 | 11 | 15 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Process for manufacturing of antigen-specific T lymphocytes8 Sep 2026US 12,729,369 B2Gdanski Uniwersytet Medyczny
- Systems and methods for cell culturing7 Jul 2026US 12,674,127 B2Flaskworks, LLC
- Methods for treating an immune disorder-related disease by reducing autoreactivity in a T cell compartment9 Jun 2026US 12,649,905 B2Hackensack University Medical Center
- Production of a bioengineered lung28 Apr 2026US 12,612,602 B2Board of Regents, The University of Texas System
- Nerve guidance conduit comprising neural crest stem-like cells and/or Schwann cell precursor-like cells and methods of making and using the same14 Apr 2026US 12,599,634 B2The Trustees of the University of Pennsylvania
- Cancer models1 Oct 2026US 2026/0297534 A1Carcinotech Ltd
- Single b-cell cultivation method24 Sep 2026US 2026/0285949 A1Hoffmann-La Roche Inc.
- Systems and methods for cell culturing24 Sep 2026US 2026/0286267 A1Flaskworks, LLC
- Microglia-sufficient brain organoids3 Sep 2026US 2026/0258354 A1Agency for Science, Technology and Research
- Lung organoid for high throughput drug screening20 Aug 2026US 2026/0242742 A1The Royal Institution for the Advancement of Learning/Mcgill University
Most cited
By later US patents
- Immunogenic epitope for immunotherapy117US 8,080,634 B2Immatics Biotechnologies GmbH · 2011
- Immunogenic epitopes for immunotherapy113US 9,511,128 B2Immatics Biotechnologies GmbH · 2016
- Immunogenic epitopes for immunotherapy106US 8,669,230 B2Immatics Biotechnologies GmbH · 2014
- Immunogenic epitopes for immunotherapy106US 9,950,048 B2Immatics Biotechnologies GmbH · 2018
- Immunotherapy against neuronal and brain tumors53US 10,420,800 B2Immatics Biotechnologies GmbH · 2019